View in EDS HTML Full Text PDF Full Text

Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.

Saved in:
Bibliographic Details
Title: Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.
Authors: Huang SY; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Shimizu K; Department of Hematology/Oncology, Higashi Nagoya National Hospital, Nagoya, Japan., Chng WJ; Department of Hematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Republic of Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Republic of Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Republic of Singapore., Chang CS; Department of Internal Medicine, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan., Wong RS; Sir Y.K. Pao Centre for Cancer and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China., Gao S; Amgen Asia Holding Ltd., Hong Kong SAR, China., Wang Y; Amgen Inc., Thousand Oaks, CA, USA., Gordon SW; Amgen Asia Holding Ltd., Hong Kong SAR, China., Glennane A; Amgen Inc., Thousand Oaks, CA, USA., Min CK; Department of Hematology, Seoul St. Mary's Hospital, Seoul, Republic of Korea. ckmin@catholic.ac.kr.
Source: Advances in therapy [Adv Ther] 2020 Jul; Vol. 37 (7), pp. 3404-3416. Date of Electronic Publication: 2020 Jun 10.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32524500
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+SY%22">Huang SY</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yoon+SS%22">Yoon SS</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shimizu+K%22">Shimizu K</searchLink>; Department of Hematology/Oncology, Higashi Nagoya National Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Chng+WJ%22">Chng WJ</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Republic of Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Republic of Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Republic of Singapore.<br /><searchLink fieldCode="AU" term="%22Chang+CS%22">Chang CS</searchLink>; Department of Internal Medicine, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wong+RS%22">Wong RS</searchLink>; Sir Y.K. Pao Centre for Cancer and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Gao+S%22">Gao S</searchLink>; Amgen Asia Holding Ltd., Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+SW%22">Gordon SW</searchLink>; Amgen Asia Holding Ltd., Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Glennane+A%22">Glennane A</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Min+CK%22">Min CK</searchLink>; Department of Hematology, Seoul St. Mary's Hospital, Seoul, Republic of Korea. ckmin@catholic.ac.kr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2020 Jul; Vol. 37 (7), pp. 3404-3416. <i>Date of Electronic Publication: </i>2020 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32524500
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-020-01395-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3404
    Titles:
      – TitleFull: Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang SY
      – PersonEntity:
          Name:
            NameFull: Yoon SS
      – PersonEntity:
          Name:
            NameFull: Shimizu K
      – PersonEntity:
          Name:
            NameFull: Chng WJ
      – PersonEntity:
          Name:
            NameFull: Chang CS
      – PersonEntity:
          Name:
            NameFull: Wong RS
      – PersonEntity:
          Name:
            NameFull: Gao S
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Gordon SW
      – PersonEntity:
          Name:
            NameFull: Glennane A
      – PersonEntity:
          Name:
            NameFull: Min CK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2020 Jul
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1